Clinical Trial Update: Nitric Oxide to Improve Blood Flow in Sickle Cell Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating inhaled nitric oxide to improve blood flow in sickle cell anemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Sickle Cell Anemia | Phase 2 | Status: COMPLETED